Immunohistochemical and biochemical studies demonstrate a distinct profile of α-Synuclein permutations in multiple system atrophy

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 9, 2000, Pages 830-841

  Duda, John E ^a   Giasson, Benoit I ^a   Gur, Tamar L ^a   Montine, Thomas J ^b   Robertson, David ^b   Biaggioni, Italo ^b   Hurtig, Howard I ^a   Stern, Matthew B ^a   Gollomp, Steven M ^a   Grossman, Murray ^a   Lee, Virginia M Y ^a   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Alpha synuclein; Dementia with Lewy bodies; Glial cytoplasmic inclusions; Lewy bodies; Multiple system atrophy; Parkinson disease; Synucleinopathies

Indexed keywords

ALPHA SYNUCLEIN; EPITOPE; PROTEIN ANTIBODY;

ADULT; AGED; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROCESSING; SHY DRAGER SYNDROME; WHITE MATTER;

EID: 0033800039     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.9.830     Document Type: Article

References (52)

1. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy
2. Multiple system atrophy: A sporadic synucleinopathy
3. The definition of multiple system atrophy: A review of recent developments
4. Widespread alterations of alpha-synuclein in multiple system atrophy
5. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
6. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein
7. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
8. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
9. NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
10. Multiple-system atrophy: A new alpha-synuclein disease?
11. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
12. Identification of two distinct synucleins from human brain
13. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch
14. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
15. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?
16. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
17. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases
18. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with Lewy bodies
19. G209A mutation in the alpha-synuclein gene is rare and not associated with sporadic Parkinson's disease
20. No mutation of G209A in the alpha-synuclein gene in sporadic Parkinson's disease among Taiwan Chinese
21. Lack of mutation G209A in the alpha-synuclein gene in French patients with familial and sporadic Parkinson's disease
22. No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy
23. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom
24. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes
25. Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation
26. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
27. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
28. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
29. Alpha-synuclein in Lewy bodies
30. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
31. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders
32. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease
33. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in lewy bodies of Parkinson's disease
34. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies
35. Diagnostic criteria for Parkinson disease
36. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
37. Consensus statement on the diagnosis of multiple system atrophy
38. Distribution of tau proteins in the normal human central and peripheral nervous system
39. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro
40. Neuronal inclusions in the dentate fascia in patients with multiple system atrophy
41. Axon pathology in Parkinson's disease and lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein
42. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology
43. Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy)
44. Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: Immunocytochemical and ultrastructural study
45. Ubiquitin-positive inclusions in different types of multiple system atrophy: Distribution and specificity
46. Cognitive performance in multiple system atrophy
47. Myelin degeneration in multiple system atrophy detected by unique antibodies
48. Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies
49. Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components
50. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies
51. Lewy bodies of Parkinson's disease contain neurofilament antigens
52. Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease